Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Eichenbaum GE"'
Autor:
Lim HK; Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, PA, USA., Chen J; Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, PA, USA., Lam W; Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, PA, USA., Gong Y; Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, PA, USA., Leclercq L; Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Beerse, Belgium., Silva J; Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, PA, USA., Salter R; Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, PA, USA., Berwaerts J; Amgen Inc, Thousand Oaks, CA, USA., Gelotte CK; Johnson & Johnson Consumer Inc, Fort Washington, PA, USA., Vakil AM; Johnson & Johnson Consumer Inc, Fort Washington, PA, USA., Eichenbaum GE; Johnson & Johnson, New Brunswick, NJ, USA., Kuffner EK; Johnson & Johnson Consumer Inc, Fort Washington, PA, USA. Electronic address: EKuffner@its.jnj.com., Flores CM; Janssen Research & Development, San Diego, CA, USA.
Publikováno v:
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2023 Mar 16, pp. 105379. Date of Electronic Publication: 2023 Mar 16.
Autor:
Zhou J; Janssen Research & Development, LLC, Raritan, NJ, USA., De Jonghe S; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium., Codd EE; Janssen Research & Development, LLC, Raritan, NJ, USA., Weiner S; Janssen Research & Development, LLC, Spring House, PA, USA., Gallacher D; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium., Stahle P; Janssen Research & Development, LLC, Spring House, PA, USA., Kelley MF; Janssen Research & Development, LLC, Spring House, PA, USA., Kuffner EK; Johnson & Johnson Consumer Companies, Fort Washington, PA, USA. Electronic address: EKuffner@its.jnj.com., Flores CM; Janssen Research & Development, San Diego, CA, USA., Eichenbaum GE; Office of the Chief Medical Officer, Johnson & Johnson, New Brunswick, NJ, USA.
Publikováno v:
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2023 Jan 04, pp. 105334. Date of Electronic Publication: 2023 Jan 04.
Autor:
Gelotte CK; Johnson & Johnson Consumer Inc., Fort Washington, PA, USA., Vakil AM; Johnson & Johnson Consumer Inc., Fort Washington, PA, USA., Berwaerts J; Amgen Inc., Thousand Oaks, CA, USA., Zimmerman BA; Johnson & Johnson Consumer Inc., Fort Washington, PA, USA., Eichenbaum GE; Johnson & Johnson Inc., New Brunswick, NJ, USA., Flores CM; Janssen R&D US, San Diego, CA, USA., Kuffner EK; Johnson & Johnson Inc., New Brunswick, NJ, USA. Electronic address: EKuffner@its.jnj.com.
Publikováno v:
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2022 Oct; Vol. 134, pp. 105236. Date of Electronic Publication: 2022 Aug 05.